Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States

References

• Al-Dakkak, I., Patel, S., McCann, E., Gadkari, A., Prajapati, G., & Maiese, E. M. (2013). The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis. AIDS Care, 25(4), 400–414. doi: 10.1080/09540121.2012.712667
   PubMed Web of Science ®Google Scholar
• Bae, J. W., Guyer, W., Grimm, K., & Altice, F. L. (2011). Medication persistence in the treatment of HIV infection: A review of the literature and implications for future clinical care and research. Aids (london, England), 25(3), 279–290. doi:10.1097/QAD.0b013e328340feb0
   PubMed Web of Science ®Google Scholar
• Beer, L., Heffelfinger, J., Frazier, E., Mattson, C., Roter, B., Barash, E., … Valverde, E. (2012). Use of and adherence to antiretroviral therapy in a large U.S. Aample of HIV-infected adults in care, 2007-2008. The Open Aids Journal, 6, 213–223. doi: 10.2174/1874613601206010213
   PubMedGoogle Scholar
• Blair, J., McNaghten, A. D., Beer, L., Bertolli, J., Frazier, E., Johnson, C., … Flagg, E. (2010). Clinical and behavioral characteristics of adults receiving medical care for HIV infection, 2005 pilot data collection cycle HIV Special Surveillance Report 6.
   Google Scholar
• Caims, G. (2009). ‘Drug holidays’ best predictor of treatment failure, adherence studies find. Retrieved from http://www.aidsmap.com/Drug-holidays-best-predictor-of-treatment-failure-adherence-studies-find/page/1436900/
   Google Scholar
• Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institutes of Health, American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of AIDS Care, National Minority AIDS Council, and Urban Coalition for HIV/AIDS Prevention Services. (2014). Recommendations for HIV prevention with adults and adolescents with HIV in the United States. In.
   Google Scholar
• Claborn, K. R., Meier, E., Miller, M. B., & Leffingwell, T. R. (2015). A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychology, Health & Medicine, 20(3), 255–265. doi: 10.1080/13548506.2014.945601
   PubMed Web of Science ®Google Scholar
• Claborn, K. R., Miller, M. B., & Meier, E. (2015). Initial validation of the HIV treatment regimen fatigue scale for adults prescribed antiretroviral therapy. The Journal of the Association of Nurses in AIDS Care, 26(4), 308–315. doi: 10.1016/j.jana.2015.01.005
   PubMed Web of Science ®Google Scholar
• Claborn, K., Miller, M. B., Meier, E., & Carbone, S. (2017). Development of a conceptual etiological model of treatment regimen fatigue among patients engaged in HIV care: A qualitative study. The Journal of the Association of Nurses in AIDS Care, 28(4), 479–490. doi: 10.1016/j.jana.2017.02.008
   PubMed Web of Science ®Google Scholar
• Conway, B. (2007). The role of adherence to antiretroviral therapy in the management of HIV infection. Journal of Acquired Immune Deficiency Syndromes, 45(1), S14–S18. doi: 10.1097/QAI.0b013e3180600766
   PubMedGoogle Scholar
• Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: Terminology and definitions. Value in Health, 11(1), 44–47. doi: 10.1111/j.1524-4733.2007.00213.x
   PubMed Web of Science ®Google Scholar
• Strategies for Management of Antiretroviral Therapy Study, G., El-Sadr, W. M., Lundgren, J., Neaton, J. D., Gordin, F., Abrams, D., & Rappoport, C. (2006). CD4+ count-guided interruption of antiretroviral treatment. New England Journal of Medicine, 355(22), 2283–2296. doi: 10.1056/NEJMoa062360
   PubMed Web of Science ®Google Scholar
• Eshleman, S. H., Hudelson, S. E., Redd, A. D., Swanstrom, R., Ou, S. S., Zhang, X. C., … Cohen, M. S. (2017). Treatment as prevention: Characterization of partner infections in the HIV prevention trials network 052 trial. Journal of Acquired Immune Deficiency Syndromes, 74(1), 112–116. doi: 10.1097/QAI.0000000000001158
   PubMed Web of Science ®Google Scholar
• Flickinger, T. E., Saha, S., Roter, D., Korthuis, P. T., Sharp, V., Cohn, J., … Beach, M. C. (2016). Clinician empathy is associated with differences in patient-clinician communication behaviors and higher medication self-efficacy in HIV care. Patient Education and Counseling, 99(2), 220–226. doi: 10.1016/j.pec.2015.09.001
   PubMed Web of Science ®Google Scholar
• Frankel, M. R., McNaghten, A. D., Shapiro, M. F., Sullivan, P. S., Berry, S. H., Johnson, C. H., … Bozzette, S. A. (2012). A probability sample for monitoring the HIV-infected population in care in the U.S. And in selected states. Open AIDS Journal, 1 (M21), 67–76. doi: 10.2174/1874613601206010067
   Google Scholar
• Genberg, B. L., Wilson, I. B., Bangsberg, D. R., Arnsten, J., Goggin, K., Remien, R. H., … Investigators, M. (2012). Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. Aids (london, England), 26(11), 1415–1423. doi: 10.1097/QAD.0b013e328354bed6
   PubMed Web of Science ®Google Scholar
• Glass, T. R., De Geest, S., Weber, R., Vernazza, P. L., Rickenbach, M., Furrer, H., … Bucher, H. C. (2006). Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: The Swiss HIV cohort study. Journal of Acquired Immune Deficiency Syndromes, 41(3), 385–392. doi: 10.1097/01.qai.0000186371.95301.52
   PubMed Web of Science ®Google Scholar
• Glass, T. R., Sterne, J. A., Schneider, M. P., De Geest, S., Nicca, D., Furrer, H., … Swiss, H. I. V. C. S. (2015). Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. Aids (london, England), 29(16), 2195–2200. doi: 10.1097/QAD.0000000000000782
   PubMed Web of Science ®Google Scholar
• Gulick, R. M. (2002). Structured treatment interruption in patients infected with HIV: A new approach to therapy. Drugs, 62(2), 245–253. doi: 10.2165/00003495-200262020-00001
   PubMed Web of Science ®Google Scholar
• Gulick, R. M. (2010). Antiretroviral treatment 2010: Progress and controversies. Journal of Acquired Immune Deficiency Syndromes, 55(1), S43–S48. doi: 10.1097/QAI.0b013e3181f9c09e
   PubMedGoogle Scholar
• Haberer, J. E., Musinguzi, N., Boum, Y., Siedner, M. J., Mocello, A. R., Hunt, P. W., … Bangsberg, D. R. (2015). Duration of antiretroviral therapy adherence interruption is associated with risk of virologic rebound as determined by real-time adherence monitoring in rural Uganda. Journal of Acquired Immune Deficiency Syndromes, 70(4), 386–392. doi: 10.1097/QAI.0000000000000737
   PubMed Web of Science ®Google Scholar
• Heeringa, S., West, B. T., & Berglund, P. A. (2010). Applied survey data analysis. Boca Raton, FL: Chapman & Hall/CRC.
   Google Scholar
• Ing, E. C., Bae, J. W., Maru, D. S., & Altice, F. L. (2013). Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy. AIDS and Behavior, 17(1), 113–121. doi: 10.1007/s10461-011-0082-0
   PubMed Web of Science ®Google Scholar
• Kavasery, R., Galai, N., Astemborski, J., Lucas, G. M., Celentano, D. D., Kirk, G. D., & Mehta, S. H. (2009). Nonstructured treatment interruptions among injection drug users in Baltimore, MD. Journal of Acquired Immune Deficiency Syndromes, 50(4), 360–366. doi: 10.1097/QAI.0b013e318198a800
   PubMed Web of Science ®Google Scholar
• Knobel, H., Urbina, O., Gonzalez, A., Sorli, M. L., Montero, M., Carmona, A., & Guelar, A. (2009). Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up. HIV Medicine, 10(6), 364–369. doi: 10.1111/j.1468-1293.2009.00696.x
   PubMed Web of Science ®Google Scholar
• Kranzer, K., & Ford, N. (2011). Unstructured treatment interruption of antiretroviral therapy in clinical practice: A systematic review. Tropical Medicine & International Health, 16(10), 1297–1313. doi: 10.1111/j.1365-3156.2011.02828.x
   PubMed Web of Science ®Google Scholar
• Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. doi: 10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Loutfy, M. R., Wu, W., Letchumanan, M., Bondy, L., Antoniou, T., Margolese, S., … Rochon, P. A. (2013). Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One, 8(2), 1–12. doi:10.1371/journal.pone.0055747
   Web of Science ®Google Scholar
• Marzel, A., Shilaih, M., Yang, W. L., Boni, J., Yerly, S., Klimkait, T., … Swiss, H. I. V. C. S. (2016). HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV cohort study. Clinical Infectious Diseases, 62(1), 115–122. doi: 10.1093/cid/civ732
   PubMed Web of Science ®Google Scholar
• McPherson-Baker, S., Malow, R. M., Penedo, F., Jones, D. L., Schneiderman, N., & Klimas, N. G. (2000). Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care, 12(4), 399–404. doi: 10.1080/09540120050123792
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Parienti, J. J., Uthman, O. A., Gross, R., Dowdy, D. W., Sax, P. E., … Giordano, T. P. (2014). Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Journal of Biochemistry and Molecular Biology, 58(9), 1297–1307. doi: 10.1093/cid/ciu046
   Google Scholar
• Oyugi, J. H., Byakika-Tusiime, J., Ragland, K., Laeyendecker, O., Mugerwa, R., Kityo, C., … Bangsberg, D. R. (2007). Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. Aids (london, England), 21(8), 965–971. doi: 10.1097/QAD.0b013e32802e6bfa
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
   Google Scholar
• Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., … Indiana, H. I. V. O. I. T. (2016). HIV infection linked to injection Use of oxymorphone in indiana, 2014-2015. New England Journal of Medicine, 375(3), 229–239. doi: 10.1056/NEJMoa1515195
   PubMed Web of Science ®Google Scholar
• Särndal, C., & Lundström, S. (2005). Estimation in surveys with nonresponse. Hoboken, NJ: Wiley.
   Google Scholar
• Siegel, L., & El-Sadr, W. (2006). New persepectives in HIV treatment interruption: The SMART study. The PRN Notebook, 11(2), 8–9.
   Google Scholar
• Spacek, L. A., Shihab, H. M., Kamya, M. R., Mwesigire, D., Ronald, A., Mayanja, H., … Quinn, T. C. (2006). Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Journal of Biochemistry and Molecular Biology, 42(2), 252–259. doi: 10.1086/499044
   Google Scholar
• Van Handel, M. M., Rose, C. E., Hallisey, E. J., Kolling, J. L., Zibbell, J. E., Lewis, B., … Brooks, J. T. (2016). County-Level vulnerability assessment for rapid dissemination of HIV or HCV infections Among persons Who inject drugs, United States. Journal of Acquired Immune Deficiency Syndromes, 73(3), 323–331. doi: 10.1097/QAI.0000000000001098
   PubMed Web of Science ®Google Scholar
• Wohl, D. A., Panter, A. T., Kirby, C., Magnus, B. E., Hudgens, M. G., Allmon, A. G., & Mollan, K. R. (2017). Estimating HIV medication adherence and persistence: Two instruments for clinical and research Use. AIDS and Behavior, 22(3), 948–960. doi:10.1007/s10461-017-1772-z
   Web of Science ®Google Scholar
• Yazdanpanah, Y., Wolf, L. L., Anglaret, X., Gabillard, D., Walensky, R. P., Moh, R., … Investigators, C. E.-I. (2010). CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: Projecting beyond clinical trials. Antiviral Therapy, 15(3), 351–361. doi: 10.3851/IMP1542
   PubMed Web of Science ®Google Scholar